NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $33,000 | -45.9% | 35,400 | -22.9% | 0.00% | – |
| Q4 2015 | $61,000 | -41.9% | 45,900 | 0.0% | 0.00% | – |
| Q3 2015 | $105,000 | +41.9% | 45,900 | 0.0% | 0.00% | – |
| Q2 2015 | $74,000 | +13.8% | 45,900 | +12.5% | 0.00% | – |
| Q1 2015 | $65,000 | -36.9% | 40,800 | -25.4% | 0.00% | – |
| Q4 2014 | $103,000 | +14.4% | 54,700 | -19.9% | 0.00% | – |
| Q3 2014 | $90,000 | -10.9% | 68,300 | 0.0% | 0.00% | – |
| Q2 2014 | $101,000 | -19.2% | 68,300 | +1.0% | 0.00% | – |
| Q1 2014 | $125,000 | -32.8% | 67,596 | -24.6% | 0.00% | – |
| Q4 2013 | $186,000 | -52.8% | 89,696 | -39.7% | 0.00% | – |
| Q3 2013 | $394,000 | -7.9% | 148,696 | -7.2% | 0.00% | – |
| Q2 2013 | $428,000 | – | 160,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |